These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 27804118)

  • 1. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Liu J; Gao L; Zang D
    PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Xu Z; Henderson RD; David M; McCombe PA
    PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of MIP-1α in CSF and serum of ALS.
    Yang X; Gao L; Wu X; Zhang Y; Zang D
    Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study.
    Sun Q; Yang F; Wang H; Cui F; Li Y; Li S; Ren Y; Lan W; Li M; Zhu W; Sun X; He Z; Zhao X; Yang L; Huang X
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):186-191. PubMed ID: 30652532
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the levels of CSF and serum factors in ALS.
    Guo J; Yang X; Gao L; Zang D
    Brain Behav; 2017 Mar; 7(3):e00637. PubMed ID: 28293476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.